Target Name: MIR3074
NCBI ID: G100422842
Review Report on MIR3074 Target / Biomarker Content of Review Report on MIR3074 Target / Biomarker
MIR3074
Other Name(s): hsa-mir-3074 | hsa-miR-3074-5p | hsa-miR-3074-3p | MicroRNA 3074 | microRNA 3074 | mir-3074

MIR3074: A Potential Drug Target and Biomarker for Multiple Chronic Diseases

MIR3074 is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker for multiple chronic diseases. Its unique structure and function have made it an attractive target for researchers to investigate.

MIR3074 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. It is expressed in a variety of tissues and cells and can interact with other molecules to regulate gene expression.

One of the defining features of MIR3074 is its unique structure. It is a single-stranded RNA molecule that contains 20 amino acid residues at its C-terminus and a single uracil residue at its N-terminus. Its unique shape and size make it distinct from other miRNAs.

MIR3074 has been shown to play a role in a variety of biological processes. For example, it has been shown to regulate gene expression involved in cell adhesion, migration, and invasion. It has also been shown to play a role in cell survival and proliferation.

MIR3074 has also been shown to be involved in the development and progression of several chronic diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This makes it an attractive target for researchers to investigate as a potential drug or biomarker.

One of the potential benefits of MIR3074 as a drug target is its small size and simple structure, which makes it easier to manipulate and study. It is also a good candidate for small molecule inhibitors, which are often more effective than antibodies in targeting and inhibiting miRNA activity.

In addition to its potential as a drug target, MIR3074 has also been identified as a potential biomarker for several chronic diseases. For example, it has been shown to be downregulated in several neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. This suggests that MIR3074 may be a useful biomarker for these diseases.

Furthermore, MIR3074 has also been shown to be involved in the regulation of cell cycle progression, which is a critical process involved in the development and progression of many diseases. This suggests that it may be a useful target for inhibitors of cell cycle progression, which could be useful for treating a variety of diseases.

In conclusion, MIR3074 is a unique and promising target for drug research and biomarker development. Its small size and simple structure make it an attractive candidate for small molecule inhibitors, while its role in the regulation of cell cycle progression and its potential as a biomarker for multiple chronic diseases make it a promising target for researchers to investigate further. Further studies are needed to fully understand the potential of MIR3074 as a drug target and biomarker.

Protein Name: MicroRNA 3074

The "MIR3074 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3074 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184